Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Human parvovirus B19 genotype 1 in suspected dengue patients of Tefé, Amazonas State, Brazil.

Figueiredo RMP, Souza VC, Nascimento VAD, Naveca FG.

Rev Soc Bras Med Trop. 2019 Sep 5;52:e20190304. doi: 10.1590/0037-8682-0304-2019.

2.

Prevalence of self-reported dengue infections in Manaus Metropolitan Region: a cross-sectional study.

Tiguman GMB, Silva MT, Souza KM, Galvao TF.

Rev Soc Bras Med Trop. 2019 Sep 5;52:e20190232. doi: 10.1590/0037-8682-0232-2019.

3.

Dengue: 30 years of cases in an endemic area.

Monteiro DCS, Souza NV, Amaral JC, Lima KB, Araújo FMC, Ramalho ILC, Martins VEP, Colares JKB, Cavalcanti LPG, Lima DM.

Clinics (Sao Paulo). 2019;74:e675. doi: 10.6061/clinics/2019/e675. Epub 2019 Sep 9.

4.

Isolating and identifying fungi to determine whether their biological properties have the potential to control the population density of mosquitoes.

Wasinpiyamongkol L, Kanchanaphum P.

Heliyon. 2019 Aug 31;5(8):e02331. doi: 10.1016/j.heliyon.2019.e02331. eCollection 2019 Aug.

5.

Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination.

Bradt V, Malafa S, von Braun A, Jarmer J, Tsouchnikas G, Medits I, Wanke K, Karrer U, Stiasny K, Heinz FX.

NPJ Vaccines. 2019 Sep 6;4:38. doi: 10.1038/s41541-019-0133-5. eCollection 2019.

6.

Authors' response to the letter to the editor entitled: Co-circulation of dengue, chikungunya, and Zika viruses and cross-protection.

Rico-Mendoza A, Porras-Ramírez A, Chang A, Encinales L, Lynch R.

Rev Panam Salud Publica. 2019 Aug 22;43:e77. doi: 10.26633/RPSP.2019.77. eCollection 2019. No abstract available.

7.

Co-circulation of dengue, chikungunya, and Zika viruses and cross-protection.

Joob B, Wiwanitkit V.

Rev Panam Salud Publica. 2019 Aug 30;43:e75. doi: 10.26633/RPSP.2019.75. eCollection 2019. No abstract available.

8.

Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?

Valdés I, Lazo L, Hermida L, Guillén G, Gil L.

Front Immunol. 2019 Aug 27;10:1956. doi: 10.3389/fimmu.2019.01956. eCollection 2019. Review.

9.

Secondary dengue infection in immunocompetent murine model leads to heart tissue damage.

Jácome FC, Teixeira AL, Coutinho DD, Costa AD, Caldas GC, Nunes MA, Barth OM, Barreto-Vieira DF.

Acta Virol. 2019;63(3):292-300. doi: 10.4149/av_2019_309.

PMID:
31507195
10.

Synthetic peptide optimization improves the inhibition of dengue NS2B-NS3 protease and dengue replication in vitro.

Abdulrahman AY, Rothan HA, Khazali AS, Teoh TC, Daher AM, Yusof R.

Acta Virol. 2019;63(3):278-285. doi: 10.4149/av_2019_305.

PMID:
31507193
11.

Transgenic Aedes aegypti Mosquitoes Transfer Genes into a Natural Population.

Evans BR, Kotsakiozi P, Costa-da-Silva AL, Ioshino RS, Garziera L, Pedrosa MC, Malavasi A, Virginio JF, Capurro ML, Powell JR.

Sci Rep. 2019 Sep 10;9(1):13047. doi: 10.1038/s41598-019-49660-6.

12.

Serum LPS Associated with Hantavirus and Dengue Disease Severity in Barbados.

Douglas KO, Samuels TA, Gittens-St Hilaire M.

Viruses. 2019 Sep 9;11(9). pii: E838. doi: 10.3390/v11090838.

13.

Green Micro- and Nanoemulsions for Managing Parasites, Vectors and Pests.

Pavoni L, Pavela R, Cespi M, Bonacucina G, Maggi F, Zeni V, Canale A, Lucchi A, Bruschi F, Benelli G.

Nanomaterials (Basel). 2019 Sep 9;9(9). pii: E1285. doi: 10.3390/nano9091285. Review.

Supplemental Content

Loading ...
Support Center